Analyst Ratings for BioMarin Pharmaceutical Inc. (BMRN)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/27/2011 | Deutsche Bank | N/A | Upgrade | Buy (N/A) |
40.00 (N/A) |
30.83 (33.64) |
9.11% | Details |
| 9/16/2011 | RBC Capital | N/A | New Coverage | Outperform (N/A) |
36.00 (N/A) |
30.35 (33.64) |
10.84% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
